Introduction
Cryptococcosis of the central nervous system develops quite rapidly and results in progressive deterioration and death (Stein and Burdon, 1960; Fujita et al., 1981) . Demonstration of capsulate yeast-like organisms by India ink preparation is a simple and rapid technique (Koshi et al., 1964; Ajello et al., 1966) . When only a few organisms are present or in the early stages of the disease, demonstration of organisms by India ink may not always be successful. Cultural isolation and confirmation may take many days to weeks. The fluorescent antibody test for cryptococcus, though rapid, may not be available to all.
Serological tests such as latex agglutination (LA), (Bindschadler and Bennett, 1968 ; Dolan, 1972) and complement fixation (CF) (Bindschadler and Bennett, 1968 ) have been described for the detection of cryptococcus antigen in meningitis and other forms of cryptococcosis. The staphylococcal coagglutination (COA) technique developed by Christensen et al. (1973) was applied by Maccani (1981) to the presumptive identification of Cryptococcus neoformans serotypes after isolation. We have extended the COA test for the rapid diagnosis of cryptococcal meningitis by antigen detection in CSF and for testing for antigenaemia in patients with cryptococcosis. Subsequently, we attempted to correlate the numbers of C. neoformans in the CSF and the detection of antigen in CSF or serum by the COA test.
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Materials and methods
Controls
Testing CSF from normal healthy individuals was not feasible in our study. However, sera from 50 normal healthy individuals and from 25 patients who were positive for rheumatoid arthritis (RA) factor were included as controls. Faeces, throat and skin swabs from the 50 healthy controls, cultured on Sabouraud Dextrose Agar (SDA) and Brain Heart Infusion Agar (BHIA) were negative for cryptococci.
Subjects
A group of 115 patients with suspected fungal meningitis and another group of 11 8 patients with chronic meningitis were included in the study.
Examination of CSF
CSF specimens from all patients were examined by Gram's stain and in India ink preparations. Repeat CSF specimens were examined at intervals of 2-10 days, 4-8 times in some patients. CSF sediments were cultured for yeasts on two sets of SDA and BHIA slopes, Beef Infusion Blood Agar (BIBA) plates, and in Thioglycollate Broth. One set of the slopes and plates was incubated at 37°C and the other at 2530°C; the thioglycollate broths were incubated at 37°C. For colony counts, 0.01 ml, sampled with a standard 4-mm platinum loop, was streaked on a BHIA plate and incubated at 37°C. Conventional methods (Ajello et al., 1966) were followed for the identification of C. neoformans; these included fermentation reactions and assimilation of various sugars, nitrate reduction, urease and oxidase tests, and chlamydospore and germ-tube formation.
Animal pathogenicity of all 11 C. neoformans isolates was tested by intracerebral and intraperitoneal inoculation of 4-week-old white mice, two animals being used for each route (Khan et al., 1959) . The mice were killed when the intracerebrally inoculated animals showed signs of sickness between the 6th and the 14th day (ruffling of fur, swelling of head and drowsiness), but before death so as to recover the organisms with capsules intact. The mice inoculated intraperitoneally showed signs of sickness between the 20th and the 40th day.
Cryptococcus neoformans COA test
Concurrent with the mycological examination, 0.5 ml of CSF was first inactivated by heating in a water bath at 100°C for 30 min, cooled and tested by COA. Tests were performed on a ceramic ring slide with 0.05 ml of both heated CSF and COA reagent.
C. neoformans polysaccharide antigen prepared as recommended by Scott et al. (1980) and PBS were used as positive and negative controls respectively. Each CSF was also tested with staphylococci treated with preimmune rabbit serum (PIS) to exclude nonspecific reactions. The clumping and clearing of positive reactions were very easily observed and they were graded from 1 + to 4 + reactions.
Furthermore, sera from 40 of the 115 subjects with suspected fungal meningitis, including the 1 1 patients who yielded cryptococci from CSF cultures, were also tested for antigen detection by the COA test. Blood from all 40 patients was also cultured for yeasts (Myers and Koshi, 1982) , but not quantitatively.
COA blocking test
To confirm the specificity of the COA reaction, a blocking test was performed. For this, 50p1 of heat treated CSF at the dilution at which COA was maximal, was mixed with 50 p1 of C. neoformans antiserum. The mixture was incubated at 37°C for 30 min and centrifuged at 2500 rpm for 15 min, and the supernate was tested in the COA test, to note whether the cryptococcus antigen present in the CSF was specifically blocked by the C. neoformans antiserum.
The COA-positive samples were also tested for the presence of RA factor by a commercial RA kit.
C . neoformans antiserum production
Antiserum to C . neoformans for the COA reagent preparations was produced in rabbits according to the method of Ikeda et al. (1982) , by inoculation of a heat killed suspension of C. neoformans serotype A (Courtesy Dr Reiss, Division of Immunology, CDC, Atlanta). The hyperimmune serum was checked by the slide agglutination method of Maccani (1981) with the immunising strain as antigen.
C. neoformans COA reagent preparation
The method of COA reagent production was essentially similar to that of Candida albicans COA reagent (Koshi et al., 1987) . C. neoformans rabbit antiserum, 0.1 ml, was mixed with 1.0ml of 10% suspension of Cowan I Staphylococcus aureus (Christensen et al., 1973; Koshi et al., 1979; Maccani, 1981 ; Koshietal., 1987) . The mixture was left at room temperature for 3 h. As controls, staphylococcal cells were sensitised similarly with PIS. The sensitised reagents were washed once with 0.03 M phosphate buffered saline (PBS) and made up to a 1% suspension of cryptococcus COA reagent and stored at 4°C until use.
To study cross reactivity, the cryptococcus COA reagent was tested with C. neoformans serotypes B, C and D, various candida species, and representative bacterial species including S. aureus, streptococci of groups A, B and C, Streptococcus pneumoniae, Neisseria meningitidis, Escherichia coli, Klebsiella sp. and Salmonella typhi. No strain of Trichosporon was available to check crossreactivity.
Number of Clinical condition subjects Results
The locally produced C. neoformans antiserum gave a slide agglutination titre of 128 with C.neoformans serotype A and, at the reference centre CDC, Atlanta, GA, the tube agglutination titre was found to be 512. The COA reagent produced with this antiserum was stable at 4°C for 9 months.
Cryptococcus COA reagent did not cross-react with the various bacterial and candida strains. However, it did react with C. neoformans serotypes B, C and D to yield 2+, 3 + and 4+ reactions respectively.
Cryptococci were isolated on several media from the CSF of all 11 patients and the blood of four. All 11 isolates gave typical reactions in sugar assimilation and fermentation tests, nitrate was not reduced, and oxidase and urease tests were positive; two of the 1 1 showed short pseudohyphae-like structures in culture. (Silva-Hunter and Cooper, 1980) . In mouse pathogenicity tests, cryptococci with capsules were demonstrated in heart blood and distant organs such as liver, spleen and lungs in all mice inoculated i.p. and in the brain of mice inoculated i.c. ; the organisms were confirmed as C. neoformans. One strain from a patient with cryptococcaemia sent to CDC, Atlanta, was confirmed as C. neoformans var. gatti (serotype B/C).
The results of the cryptococcus COA test and culture of CSF and blood from patients with suspected cryptococcal meningitis and from controls are given in 
Discussion
Rapid diagnosis of cryptococcal meningitis is necessary for timely therapy and improved prognosis. Detection of fungal antigen in serum or body fluids has been found to be more promising than antibody detection (Bindschadler and Bennett, 1968; Dolan, 1972; Kaufman and Blumer, 1973 ). The LA test, which is sensitive, is widely used as a rapid test, but may yield false positive reactions due to the presence of RA factors (Dolan, 1972; Kaufman and Blumer, 1973) . The COA test used for the rapid identification of bacterial antigens has been effectively applied by us (Koshi et al., 1987) to detect candida antigen in the serum and cyst fluid of patients with candidaemia and other candida lesions. Therefore, we extended the COA test to detect cryptococcus antigen in the CSF and serum of patients with meningitis.
The cryptococcus COA test was found to be specific for cryptococcus antigen detection because of the absence of cross-reactions with various bacterial and fungal agents, as well as its lack of reactivity with 75 control sera, including 25 that were positive for RA factor. Moreover, the blocking test we used tended to confirm the specificity of the test.
Of the 115 patients suspected of fungal meningitis, antigen was detected by the COA test in the CSF of 11 culturally confirmed cases (table I) : of these, two had primary meningitis and all the rest were secondary. Five of the latter had cirrhosis or other hepatic problems, three were post-renal transplantation and on immunosuppressive therapy, and one, a patient with chronic collagen disease, was on long term steroids.
The titre of antigen in the CSF varied from 8 to 128 by the COA test. Cryptococci were detected by Gram's stain and India ink in the CSF of 9 out of the 11 patients initially and all 11 patients on repeat examinations. The viable count of cryptococci in CSF varied from 100 to > 100 000 cfu/ml (table 11) .
There was a correlation between the microscopic findings, the cfu/ml and the titre of antigen in the CSF. Four out of the five patients with > 100 000 cfu/ml had a COA titre of 128 and in the fifth patient the titre was 64. In two cases, microscopic examination was negative initially, but became positive when the CSF counts rose from 100 and 800 to 50 000 and 1200 cells/ml respectively. Nevertheless, COA gave positive results even when microscopy was negative; COA was also positive in neat serum when CSF contained low numbers of cryptococci (e.g. even when as low as 100 cfulml). Perfect et al. (1983) found that the CSF in four patients with cryptococcal meningitis contained 104-107 cfu/ml before antifungal therapy was begun. Quantitative counts were done in all of our l l patients. In the two patients with primary cryptococcal meningitis, the COA test in CSF gave high titres and was positive in serum (titre 4); cryptococci were cultured in large numbers from CSF, i.e. 100 000 and 50 000 cfu/ml respectively and were demonstrable with India ink : blood cultures were negative. Antifungal therapy was started too late in these patients and both succumbed to the disease.
In the group of patients with secondary cryptococcosis, among the five with cirrhosis or other hepatic diseases, all except one, who had tuberculosis, had very high cfu counts and COA titres in CSF; the COA was also positive in the serum; Gram's stain and India ink preparation of CSF were also positive (table 11). Antifungal therapy was not instituted in three of these patients, and in two amphotericin B and 5-fluorocytosine were only given 30-36 days after onset and the patients died subsequently.
The patient with collagen disease and on steroids was admitted comatose and died within 72 h of admission without antifungal therapy. The steroid therapy probably aggravated the superinfec t ion.
In the three post-renal transplant patients on immunosuppressive therapy the specific diagnosis was made within 8-1 5 days after onset of symptoms. Because of regular monitoring and the early institution of amphotericin B and 5-fluorocytosine, all three patients were discharged fully recovered and were doing well up to the date of this report (1-2 years).
The many repeat COA tests and repeat cultures of CSF and blood yielded important information. A four-fold rise or fall in titre of COA was noted in six patients and a two-fold rise in three patients in whom the repeat test was made after a short interval. Thus the early diagnostic importance of the COA test was undoubted in the renal transplant and in the post-liver disease patients. The early confirmation of diagnosis enabled us to institute specific therapy as early as the 8th to the 16th day after onset. Perfect et al. (1983) also found a favourable outcome in patients who had early antifungal therapy.
Persistently high antigen titres in the CSF measured by LA test, even after antifungal therapy, were reported by Lauter (1977) and Sapico (1979) . We found that the cryptococcus antigen in CSF decreased steadily with antifungal therapy; in the three renal transplant patients, the COA titre became negative on the 32nd, 40th and 44th day respectively (table 11) .
The four patients in our series who had cryptococcaemia had secondary cryptococcal meningitis and were on steroids; two had liver disease, one had collagen vascular disease and the fourth was a post-renal transplant patient. Butler et al. (1964) reported that 12.5% of their 40 cryptococcal meningitis patients had positive blood cultures. In this study we have shown that whereas only four of the 1 1 meningitis patients had cryptococcaemia, all had antigenaemia. Blood is inhibitory to the growth of cryptococci when specific host factors are inactive and a large tissue burden of organisms is needed for detection of cryptococci in blood culture (Perfect et al., 1983) . Hence our study suggests that antigen detection in serum helps in early diagnosis of cryptococcaemia. The COA test which we applied for cryptococcal antigen detection in CSF and serum has been found to be a simple, sensitive, rapid and cost effective test, specific enough for the diagnosis of suspected cryptococcal meningitis. The early diagnostic and prognostic value of the test is noteworthy; it can be used as a rapid test to make the diagnosis early and permit prompt therapy which should improve the prognosis.
